Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Clinical trial NCT03836157 · WITHDRAWN

Trial details

NCT number: NCT03836157
Sponsor: University of Oklahoma
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer Endometrial Adenocarcinoma Endometrial Serous Adenocarcinoma Endometrial Clear Cell Adenocarcinoma

Start date: 2019-05-31
Primary completion: 2021-11-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.